EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Bifidogenic Effect of 2′-Fucosyllactose (2′-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical Trial

Tamara Lazarini iD, Karina Merini Tonon iD, Humberto Bezerra de Araujo Filho iD, Mauro Batista de Morais iD

Nutrients · 2025

DOI: 10.3390/nu17060973 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Tamara Lazarini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Postgraduate Program, Universidade Federal de São Paulo, São Paulo 04023-062, Brazil. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Infant Formula, Trisaccharides, Prebiotics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nestlé (Brazil).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast milk is rich in bioactive components, especially human milk oligosaccharides (HMOs), which are crucial for establishing gut microbiota. The 2′-FL (2-Fucosyllactose), one of the most abundant oligosaccharides in breast milk, functions as a selective prebiotic.

Objective

To examine the effect of adding 2′-FL (2-Fucosyllactose) to an infant formula containing prebiotic galacto-oligosaccharides (GOSs) and fructo-oligosaccharides (FOSs) on the gut microbiome of healthy formula-fed infants.

Methods

This study enrolled infants from three groups: an HMO experimental group (n = 29), a GOS/FOS control group (n = 30), and an exclusively breastfed (breast milk [BM]) reference group (n = 28). Fecal samples from the three groups in the first and fourth months of life were analyzed. The V3 and V4 regions of the 16S rRNA gene were amplified and sequenced on the Illumina MiSeq. ANOVA, Kruskal–Wallis, richness indices (Chao1, Shannon), UniFrac distances, and the Adonis tests were used to perform statistical analyses on the relative abundance of phyla and genera, as well as the alpha and beta-diversity of the gut microbiota.

Results

After intervention, Actinobacteriota emerged as the predominant phylum in both the HMO (60.4%) and BM (46.6%) groups. Bifidobacterium and Escherichia-Shigella were identified as the two most abundant bacterial genera in both groups. Nevertheless, the statistical analysis showed that the relative abundance of Bifidobacterium in the HMO formula-fed group after intervention was similar to that in the BM group (p > 0.05). Infants in the HMO and GOS/FOS groups showed higher relative abundance of [Ruminococcus]_gnavus_group bacteria compared to those in the BM group. Groups fed with infant formula demonstrated higher alpha-diversity of gut microbiota compared to breastfed infants (p < 0.05), at the time of admission as well as after the intervention. Beta-diversity was significantly different among the three groups, according to type of feeding. Infants fed a 2′-FL-supplemented infant formula exhibited growth comparable to that of breastfed infants throughout the intervention period, demonstrating that the formula was both safe and well tolerated.

Conclusions

Adding 2′-FL to an infant formula containing 4 g/L of GOS + FOS resulted in a stronger bifidogenic effect compared to the formula without 2′-FL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeInfant FormulaTrisaccharidesPrebioticsHumansInfantFecesFemaleMaleOligosaccharidesMilk, HumanBreast FeedingBifidobacteriumRNA, Ribosomal, 16S

Stichwörter der Autor:innen

2-fucosyllactosebreast milkfructo-oligosaccharidesgalacto-oligosaccharidesgut microbiomehuman milk oligosaccharidesinfant formula

Substanzen

2'-fucosyllactoseTrisaccharidesPrebioticsOligosaccharidesRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Nutrition Postgraduate Program, Universidade Federal de São Paulo, São Paulo 04023-062, Brazil.
  • Department of Environmental & Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
  • Division of Pediatric Gastroenterology, Universidade Federal de São Paulo, São Paulo 04023-062, Brazil.

ORCID-Profile: Tamara Lazarini, Karina Merini Tonon, Humberto Bezerra de Araujo Filho, Mauro Batista de Morais

Förderung

  • Nestlé (Brazil)

Zitieren

APA

Lazarini, T., Tonon, K. M., Araujo Filho, H. B., & Morais, M. B. (2025). Bifidogenic Effect of 2′-Fucosyllactose (2′-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical Trial. Nutrients. https://doi.org/10.3390/nu17060973

Vancouver

Lazarini T, Tonon KM, Araujo Filho HB, Morais MB. Bifidogenic Effect of 2′-Fucosyllactose (2′-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical Trial. Nutrients. 2025. doi:10.3390/nu17060973

BibTeX
@article{Lazarini2025,
  author = {Lazarini, Tamara and Tonon, Karina Merini and Araujo Filho, Humberto Bezerra de and Morais, Mauro Batista de},
  title = {Bifidogenic Effect of 2′-Fucosyllactose (2′-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical Trial},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17060973}
}
Kostenlos starten →